Publications by authors named "Shaotong Tang"

Claim this Profile
F
FAM105B Promotes Hepatocellular Carcinoma Progression and Metastasis by Activating the PI3K/AKT/MTOR Signaling Pathway and Inducing Epithelial-Mesenchymal Transition.
Liu-Lin Yang, Xing Chen, Shao-Tong Tang, Kai-Ting Huang, Gui-Yan Ye

J Hepatocell Carcinoma· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BEND3 promotes hepatocellular carcinoma progression and metastasis by activating the PI3K/AKT/mTOR pathway and inducing epithelial-mesenchymal transition.
Liu-Lin Yang, Xing Chen, Kai-Ting Huang, Shao-Tong Tang, Gui-Yan Ye

Clin Res Hepatol Gastroenterol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of immune checkpoint inhibitors at different treatment time periods on prognosis of patients with extensive-stage small-cell lung cancer.
Song Mi, Yunxin Yang, Xin Liu, Shaotong Tang, Ning Liang

Clin Transl Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of Clinicopathological Characteristics and Prognosis of Young Patients with Hepatocellular Carcinoma after Hepatectomy.
Chuan Li, Kang Chen, Xu Liu, Hao-Tian Liu, Xiu-Mei Liang, Shao-Tong Tang

J Clin Transl Hepatol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letter: are sorafenib-related adverse events associated with prolonged survival?
Jian-Xu Li, Xu Liu, Shao-Tong Tang, Guang-Lan Liang, Bang-De Xiang

Aliment Pharmacol Ther· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis